Moreover, changes in CyPA levels in patients with acute coronary syndrome (ACS) have been regarded as important indicators for assessing disease stability and prognosis, further emphasizing its significance in clinical applications (5). This evidence concerns the gene PPIA and acute coronary syndrome.